SouthState Corp’s Surmodics SRDX Stock Holding History

SouthState Corp’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,400	Closed	-$243K	–	275
2018 Q2	$243K	Buy	+4,400	New	+$203K	0.03%	244

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

SouthState Corp's SRDX Position: Q3 2018 in Review

SouthState Corp sold out of Surmodics (SRDX) in Q3 2018, closing a stake of 4,400 shares — an estimated $243K sold.

SouthState Corp first reported a position in SRDX in Q2 2018 and held it in 1 quarter. The position peaked at $243K in Q2 2018. 168 funds tracked by Wall St. Rank hold SRDX as of Q3 2018.

SouthState Corp reported no remaining Surmodics position as of Q3 2018 after selling out during the quarter.
SouthState Corp sold 4,400 Surmodics shares in Q3 2018, an estimated $243K.
SouthState Corp first reported a position in Surmodics in Q2 2018 and held it in 1 quarter.
SouthState Corp's Surmodics position peaked at $243K in Q2 2018.
168 funds tracked by Wall St. Rank held Surmodics as of Q3 2018.

Based on SouthState Corp's 13F filing for Q3 2018, filed 8 Nov 2018.